Hi Nicolas. Will complete I-Care imminently. DB

MDS-RIGHT / EUMDS annual symposium in Mannheim. MDS Experts in creative discussion on original research programme for patient benefit MDS Europe

Prof Fenaux presenting IWG MDS response criteria for clinical trials at ELN Annual Meeting. MDS Europe bloodjournal.org/content/early/…

Agreed. Positive can-do culture despite financial and HR challenges of NHS. Also proud to work for LTH.

Well worth watching: Dutch historian demolishes Fox News anchor Tucker Carlson (spectacular upper cut knock out in round three) #tax #Murdoch #Koch

Dr. Simone Green telling MDS patients about new U.K. trials in MDS at Harrogate MDS Patient Forum @leedshaem MDSUK Patient Support 🩸

Prof Dave Roberts discusses red cell genotyping including MDS. Should this now be routine? Many potential benefits but few studies. Canadian MDS data suggests may add value #BSH2019

Productive discussions at NCRI MDS subgroup. Strategy emerging with strengths in low risk MDS, registries, biobanks. Enjoying the emergence of a new generation of young UK clinician scientists. Strategy document to follow setting out research priorities #NCRI #CRUK

Marlijn presenting important data from EUMDS programme informing transfusion and iron toxicity. Further evidence for transfusion dependence as a relatively negative prognostic factor #EHA2019

Charlie Craddock delivers a deeply personal eulogy to the legend that was David Grimwade

Thrilled to co-moderate a fantastic session on #MDS sponsored by ⁦MDS Foundation⁩ with Dr. Mario Cazzola. Packed house at 7 am. Thanks to all the amazing speakers ⁦and to the audience participants who made the session lively & informative.

#ASH19 ⁦@ColemanLindsley⁩ presents patients with #AML and TP53 mutations have poor outcomes with Vyxeos or standard treatment #leusm

"Our government is complicit in an extortion that is an important contributor to income inequality in America today."—Anne Case & Angus Deaton TIME "The Sickness of Our System" time.com/5785945/health… redrawn graph from Max Roser, what I've also been writing about for some time

ELN symposium, EBMT postponed. Any societies attempting webcasts or similar virtual meetings? Preempt the future - perfect opportunity going to waste. At least video consults will become mainstream - long overdue and works well for MDS specialist consults @leedshaem MDSUK Patient Support 🩸

Recommendations for the management of patients with AML during the COVID-19 outbreak: A statement from the NCRI AML Working Party: bit.ly/3990QSx #COVID19 #COVIDー19 #covid19UK #AML #kNOwAML #AML #Bloodcancer #Haematology

Save the date! To mark #MDSWAD we’re hosting a tweet chat around patient involvement in research in #myelodysplastic syndromes on 30 Oct at 12pm GMT MDSUK Patient Support 🩸 & David Bowen. Join us at #SilenceMDSChat

Our European MDS Registry project has been accepted onto the UK NIHR research trial portfolio. Good to see that registries are gathering research currency, recognising valuable complementary role to clinical trials #MDS_EUROPE

Encouraging data - good incentive for all active sites to continue recruitment to iMERGE phase 3 trial, accepting current challenges with trial recruitment #leedshaem

Congratulations to all. The patient voice was strong in designing this study. A model for all trial development going forward. Thank you to Sophie and her team

Last Friday I held a tweet chat with MDSUK Patient Support 🩸 in honour of #MDSWAD to raise awareness of the impact of MDS and the benefits of patient involvement in research. If you missed it (or want to relive it!), you can READ the full discussion here: bit.ly/3elPKxM